{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:11:06Z","timestamp":1791591066781,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.eprac.2025.04.008","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T18:49:32Z","timestamp":1745693372000},"page":"813-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autoimmune Primary Adrenal Insufficiency: Understanding the Past, Present, and Future"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-3079","authenticated-orcid":false,"given":"Asif","family":"Surani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9942-4107","authenticated-orcid":false,"given":"Ty B.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2025.04.008_bib1","series-title":"Opuscula anatomica De renum structura","author":"Eustachius","year":"1563"},{"key":"10.1016\/j.eprac.2025.04.008_bib2","series-title":"A collection of the published writing of the late Thomas Addison, M.D., physician to Guy\u2019s Hospital","article-title":"On the constitutional and local effects of disease of the suprarenal capsules","author":"Addison","year":"1855"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.008_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4158\/EP.1.1.14","article-title":"Autoimmune Addison\u2019s disease after treatment with interleukin-2 and tumor-infiltrating lymphocytes","volume":"1","author":"Wahle","year":"1995","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2025.04.008_bib4","first-page":"742","article-title":"Addison\u2019s disease: statistical analysis of 566 cases and study of the pathology","volume":"10","author":"Guttman","year":"1930","journal-title":"Arch Pathol"},{"issue":"16","key":"10.1016\/j.eprac.2025.04.008_bib5","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM199610173351607","article-title":"Adrenal insufficiency","volume":"335","author":"Oelkers","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.eprac.2025.04.008_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1530\/EJE-13-0528","article-title":"Addison's disease: a survey on 633 patients in Padova","volume":"169","author":"Betterle","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2025.04.008_bib7","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.008_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction","volume":"23","author":"Betterle","year":"2002","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.008_bib9","first-page":"379","article-title":"Clinical and immunological characteristics of autoimmune Addison disease: a nationwide Swedish multicenter study","volume":"102","author":"Dalin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.008_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1210\/clinem\/dgad402","article-title":"Approach to the patient: diagnosis of primary adrenal insufficiency in adults","volume":"109","author":"\u00d8ksnes","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2025.04.008_bib11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ando.2017.10.010","article-title":"Group 1. Epidemiology of primary and secondary adrenal insufficiency: prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality","volume":"78","author":"Chabre","year":"2017","journal-title":"Ann Endocrinol (Paris)"},{"issue":"9935","key":"10.1016\/j.eprac.2025.04.008_bib12","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"issue":"7571","key":"10.1016\/j.eprac.2025.04.008_bib13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(68)90948-3","article-title":"Epidemiological and clinical picture of Addison's disease","volume":"2","author":"Mason","year":"1968","journal-title":"Lancet"},{"issue":"859","key":"10.1016\/j.eprac.2025.04.008_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/pgmj.73.859.286","article-title":"The prevalence of Addison's disease in Coventry, UK","volume":"73","author":"Willis","year":"1997","journal-title":"Postgrad Medical Journal"},{"issue":"6","key":"10.1016\/j.eprac.2025.04.008_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2265.1994.tb02790.x","article-title":"Eighty-six cases of Addison's disease","volume":"41","author":"Kong","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.eprac.2025.04.008_bib16","first-page":"1762","article-title":"Is the prevalence of Addison's disease underestimated?","volume":"84","author":"Laureti","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.04.008_bib17","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1210\/jc.2012-3561","article-title":"Drug prescription patterns in patients with Addison's disease: a Swedish population-based cohort study","volume":"98","author":"Bj\u00f6rnsdottir","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.008_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4158\/EP15754.OR","article-title":"Increasing prevalence of addison disease: results from a nationwide study","volume":"22","author":"Olafsson","year":"2016","journal-title":"Endocr Pract"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2025.04.008_bib19","doi-asserted-by":"crossref","first-page":"164s","DOI":"10.1016\/S0753-3322(00)80036-0","article-title":"Epidemiologic study of adrenal gland disorders in Japan","volume":"54","author":"Takayanagi","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.eprac.2025.04.008_bib20","doi-asserted-by":"crossref","first-page":"718660","DOI":"10.3389\/fendo.2021.718660","article-title":"Sex-specific limitations in physical health in primary adrenal insufficiency","volume":"12","author":"Didriksen","year":"2021","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2025.04.008_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2265.2002.01466.x","article-title":"Subjective health status in Norwegian patients with Addison's disease","volume":"56","author":"L\u00f8v\u00e5s","year":"2002","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.008_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/EJE-14-0023","article-title":"Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature","volume":"171","author":"Tiemensma","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.008_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-08-0550","article-title":"Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death","volume":"160","author":"Erichsen","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2025.04.008_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.eprac.2025.04.008_bib25","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison's disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"8809","key":"10.1016\/j.eprac.2025.04.008_bib26","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0140-6736(92)91829-W","article-title":"21-Hydroxylase, a major autoantigen in idiopathic Addison's disease","volume":"339","author":"Winqvist","year":"1992","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.eprac.2025.04.008_bib27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s40618-019-01079-6","article-title":"Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults","volume":"42","author":"Betterle","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.008_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ando.2018.03.008","article-title":"Autoimmune Addison's disease - an update on pathogenesis","volume":"79","author":"Hellesen","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6127","key":"10.1016\/j.eprac.2025.04.008_bib29","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.1.6127.1591-a","article-title":"Malignant disease presenting as Addison's disease","volume":"1","author":"Rosenthal","year":"1978","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.008_bib30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1210\/jcem.87.2.8192","article-title":"Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features","volume":"87","author":"Myhre","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2025.04.008_bib31","first-page":"2801","article-title":"Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo","volume":"81","author":"Boscaro","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.04.008_bib32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF03347492","article-title":"Assessment of adrenocortical function and autoantibodies in a baby born to a mother with autoimmune polyglandular syndrome Type 2","volume":"27","author":"Betterle","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.eprac.2025.04.008_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1530\/EJE-20-1268","article-title":"The natural history of 21-hydroxylase autoantibodies in autoimmune Addison's disease","volume":"184","author":"Wolff","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.eprac.2025.04.008_bib34","first-page":"2752","article-title":"High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase","volume":"80","author":"Falorni","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.008_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/joe.0.1170467","article-title":"The natural history of adrenal function in autoimmune patients with adrenal autoantibodies","volume":"117","author":"Betterle","year":"1988","journal-title":"J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.008_bib36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/jcem-64-3-494","article-title":"Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure","volume":"64","author":"Ahonen","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.04.008_bib37","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1210\/jc.2005-0860","article-title":"Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies","volume":"91","author":"Coco","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2025.04.008_bib38","first-page":"4434","article-title":"ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"85","author":"Gylling","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.04.008_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1285901","article-title":"Autoimmune primary adrenal insufficiency -current diagnostic approaches and future perspectives","volume":"14","author":"Wolff","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10274","key":"10.1016\/j.eprac.2025.04.008_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.008_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jcp.21727","article-title":"Investigation on human adrenocortical cell response to adenovirus and adenoviral vector infection","volume":"220","author":"Matkovic","year":"2009","journal-title":"J Cell Physiol"},{"issue":"10","key":"10.1016\/j.eprac.2025.04.008_bib42","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s007050170048","article-title":"Acute adrenal infection by HSV-1: role of apoptosis in viral replication","volume":"146","author":"Aita","year":"2001","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.008_bib43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jcp.21896","article-title":"Human cytomegalovirus productively infects adrenocortical cells and induces an early cortisol response","volume":"221","author":"Trevisan","year":"2009","journal-title":"J Cell Physiol"},{"issue":"11","key":"10.1016\/j.eprac.2025.04.008_bib44","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2016-2392","article-title":"Impact of month of birth on the risk of development of autoimmune Addison's disease","volume":"101","author":"Pazderska","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"10.1016\/j.eprac.2025.04.008_bib45","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2018.7028","article-title":"Association of stress-related disorders with subsequent autoimmune disease","volume":"319","author":"Song","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.eprac.2025.04.008_bib46","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1210\/jc.2004-1062","article-title":"Elevated serum interferon-gamma-inducible chemokine-10\/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines","volume":"90","author":"Rotondi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.008_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/joim.12162","article-title":"Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency","volume":"275","author":"Husebye","year":"2014","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.008_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2025.04.008_bib49","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.eprac.2025.04.008_bib50","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/jc.2016-1821","article-title":"A longitudinal follow-up of autoimmune polyendocrine syndrome type 1","volume":"101","author":"Bruserud","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2025.04.008_bib51","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1210\/jc.2017-00139","article-title":"Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type 1","volume":"102","author":"Orlova","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2025.04.008_bib52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1634\/theoncologist.2019-0555","article-title":"Immune checkpoint inhibitor-associated primary adrenal insufficiency: WHO VigiBase report analysis","volume":"25","author":"Grouthier","year":"2020","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.eprac.2025.04.008_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.21037\/atm-21-7006","article-title":"Immune checkpoint inhibitors and adrenal insufficiency: a large-sample case series study","volume":"10","author":"Cui","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.eprac.2025.04.008_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2018.04.001","article-title":"Immunotherapy-induced Addison's disease: a rare, persistent and potentially lethal side-effect","volume":"97","author":"Hescot","year":"2018","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.eprac.2025.04.008_bib55","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eprac.2024.03.023","article-title":"Endocrinopathies associated with immune checkpoint inhibitor use","volume":"30","author":"Kotwal","year":"2024","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.eprac.2025.04.008_bib56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.seminoncol.2023.11.003","article-title":"Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects","volume":"50","author":"Martella","year":"2023","journal-title":"Semin Oncol"},{"issue":"7","key":"10.1016\/j.eprac.2025.04.008_bib57","first-page":"2909","article-title":"Clinical review 130: Addison's disease 2001","volume":"86","author":"Ten","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.008_bib58","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.12699","article-title":"Clues for early detection of autoimmune Addison's disease - myths and realities","volume":"283","author":"Saevik","year":"2018","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.008_bib59","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S2213-8587(14)70142-1","article-title":"Diagnosis and management of adrenal insufficiency","volume":"3","author":"Bancos","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4-5","key":"10.1016\/j.eprac.2025.04.008_bib60","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.autrev.2014.01.025","article-title":"Diagnosis and classification of Addison's disease (autoimmune adrenalitis)","volume":"13","author":"Brand\u00e3o Neto","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.eprac.2025.04.008_bib61","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4158\/EP171861.OR","article-title":"Diagnostic accuracy of basal cortisol level to predict adrenal insufficiency in cosyntropin testing: results from an observational cohort study with 804 patients","volume":"23","author":"Struja","year":"2017","journal-title":"Endocr Pract"},{"issue":"11","key":"10.1016\/j.eprac.2025.04.008_bib62","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.04.008_bib63","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab022","article-title":"New cutoffs for the biochemical diagnosis of adrenal insufficiency after ACTH stimulation using specific cortisol assays","volume":"5","author":"Javorsky","year":"2021","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.008_bib64","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1210\/jc.2015-1700","article-title":"ACTH stimulation tests for the diagnosis of adrenal insufficiency: systematic review and meta-analysis","volume":"101","author":"Ospina","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.008_bib65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.008_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-16-0081","article-title":"Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency","volume":"6","author":"Quinkler","year":"2017","journal-title":"Endocr Connect"},{"issue":"6","key":"10.1016\/j.eprac.2025.04.008_bib67","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EC-18-0160","article-title":"Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency","volume":"7","author":"Frey","year":"2018","journal-title":"Endocr Connect"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.008_bib68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jc.2011-1926","article-title":"Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation","volume":"97","author":"Johannsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2025.04.008_bib69","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-17-0067","article-title":"Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study","volume":"176","author":"Nilsson","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.008_bib70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2025.04.008_bib71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/EJE-14-1114","article-title":"Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency","volume":"172","author":"Quinkler","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.04.008_bib72","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1210\/jc.2014-4060","article-title":"Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency","volume":"100","author":"Whitaker","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.04.008_bib73","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EC-16-0054","article-title":"Society for endocrinology endocrine emergency guidance: emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients","volume":"5","author":"Arlt","year":"2016","journal-title":"Endocr Connect"},{"issue":"7","key":"10.1016\/j.eprac.2025.04.008_bib74","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1210\/clinem\/dgaa256","article-title":"Residual corticosteroid production in autoimmune Addison disease","volume":"105","author":"S\u00e6vik","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2025.04.008_bib75","doi-asserted-by":"crossref","first-page":"E1927","DOI":"10.1210\/jc.2012-1680","article-title":"Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's disease","volume":"97","author":"Pearce","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.008_bib76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/jc.2013-2449","article-title":"Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1\u201324) treatment","volume":"99","author":"Gan","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.008_bib77","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1530\/EJE-16-0581","article-title":"Management of endocrine disease: regenerative therapies in autoimmune Addison's disease","volume":"176","author":"Gan","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.04.008_bib78","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1210\/clinem\/dgz287","article-title":"Residual adrenal function in autoimmune Addison's disease-effect of dual therapy with rituximab and depot tetracosactide","volume":"105","author":"Napier","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.008_bib79","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-6143.2009.02929.x","article-title":"A case of human intramuscular adrenal gland transplantation as a cure for chronic adrenal insufficiency","volume":"10","author":"Grodstein","year":"2010","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.eprac.2025.04.008_bib80","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/ajt.12296","article-title":"The first simultaneous kidney\u2013adrenal gland\u2013pancreas transplantation: outcome at 1 year","volume":"13","author":"Vouillarmet","year":"2013","journal-title":"Am J Transplant"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25001259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25001259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:24:03Z","timestamp":1749633843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25001259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1530891X25001259"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.04.008","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Primary Adrenal Insufficiency: Understanding the Past, Present, and Future","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}